CVC Technologies（4744）株式概要CVC Technologies Inc.は、様々なタイプの医薬品包装機を世界中で製造・販売しています。 詳細4744 ファンダメンタル分析スノーフレーク・スコア評価2/6将来の成長0/6過去の実績5/6財務の健全性6/6配当金3/6報酬株価収益率（ 12.2 x） TW市場（ 23.2 x）を下回っています。過去1年間で収益は75.7%増加しました リスク分析4.02%の配当はフリーキャッシュフローで十分にカバーされていない 意味のある時価総額がありません ( NT$1B )すべてのリスクチェックを見る4744 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueNT$Current PriceNT$24.908.4% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-9m2b2016201920222025202620282031Revenue NT$2.1bEarnings NT$170.2mAdvancedSet Fair ValueView all narrativesCVC Technologies Inc. 競合他社BenQ Medical TechnologySymbol: TPEX:4116Market cap: NT$1.7bLagis EnterpriseSymbol: TPEX:6730Market cap: NT$1.4bBioptik Technology IncorporationSymbol: TPEX:4161Market cap: NT$1.4bCrystalvue MedicalSymbol: TPEX:6527Market cap: NT$1.8b価格と性能株価の高値、安値、推移の概要CVC Technologies過去の株価現在の株価NT$24.9052週高値NT$40.1052週安値NT$21.20ベータ0.0171ヶ月の変化-27.09%3ヶ月変化-32.70%1年変化11.41%3年間の変化-39.86%5年間の変化-0.99%IPOからの変化-74.67%最新ニュースValuation Update With 7 Day Price Move • Jun 15Investor sentiment deteriorates as stock falls 25%After last week's 25% share price decline to NT$27.40, the stock trades at a trailing P/E ratio of 13.1x. Average forward P/E is 11x in the Medical Equipment industry in Taiwan. Total loss to shareholders of 28% over the past three years.Reported Earnings • May 15First quarter 2026 earnings released: NT$0.11 loss per share (vs NT$0.29 profit in 1Q 2025)First quarter 2026 results: NT$0.11 loss per share (down from NT$0.29 profit in 1Q 2025). Revenue: NT$240.0m (down 15% from 1Q 2025). Net loss: NT$6.16m (down 140% from profit in 1Q 2025). Over the last 3 years on average, earnings per share has increased by 85% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings.New Risk • Apr 10New minor risk - Dividend sustainabilityThe dividend is not well covered by cash flows. The company is paying a dividend despite having no free cash flows. Dividend yield: 3.0% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Market cap is less than US$100m (NT$1.80b market cap, or US$56.6m).Reported Earnings • Mar 14Full year 2025 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2025 results: EPS: NT$2.51 (up from NT$0.75 in FY 2024). Revenue: NT$1.44b (up 12% from FY 2024). Net income: NT$135.0m (up 227% from FY 2024). Profit margin: 9.3% (up from 3.2% in FY 2024). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 7.4%. Earnings per share (EPS) exceeded analyst estimates by 17%. Over the last 3 years on average, earnings per share has increased by 68% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.お知らせ • Mar 13CVC Technologies Inc., Annual General Meeting, Jun 11, 2026CVC Technologies Inc., Annual General Meeting, Jun 11, 2026. Location: 2 floor no,2, kung yeh rd., dali district, taichung city TaiwanValuation Update With 7 Day Price Move • Nov 28Investor sentiment improves as stock rises 15%After last week's 15% share price gain to NT$30.90, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 11x in the Medical Equipment industry in Taiwan. Total returns to shareholders of 24% over the past three years.最新情報をもっと見るRecent updatesValuation Update With 7 Day Price Move • Jun 15Investor sentiment deteriorates as stock falls 25%After last week's 25% share price decline to NT$27.40, the stock trades at a trailing P/E ratio of 13.1x. Average forward P/E is 11x in the Medical Equipment industry in Taiwan. Total loss to shareholders of 28% over the past three years.Reported Earnings • May 15First quarter 2026 earnings released: NT$0.11 loss per share (vs NT$0.29 profit in 1Q 2025)First quarter 2026 results: NT$0.11 loss per share (down from NT$0.29 profit in 1Q 2025). Revenue: NT$240.0m (down 15% from 1Q 2025). Net loss: NT$6.16m (down 140% from profit in 1Q 2025). Over the last 3 years on average, earnings per share has increased by 85% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings.New Risk • Apr 10New minor risk - Dividend sustainabilityThe dividend is not well covered by cash flows. The company is paying a dividend despite having no free cash flows. Dividend yield: 3.0% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Market cap is less than US$100m (NT$1.80b market cap, or US$56.6m).Reported Earnings • Mar 14Full year 2025 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2025 results: EPS: NT$2.51 (up from NT$0.75 in FY 2024). Revenue: NT$1.44b (up 12% from FY 2024). Net income: NT$135.0m (up 227% from FY 2024). Profit margin: 9.3% (up from 3.2% in FY 2024). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 7.4%. Earnings per share (EPS) exceeded analyst estimates by 17%. Over the last 3 years on average, earnings per share has increased by 68% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.お知らせ • Mar 13CVC Technologies Inc., Annual General Meeting, Jun 11, 2026CVC Technologies Inc., Annual General Meeting, Jun 11, 2026. Location: 2 floor no,2, kung yeh rd., dali district, taichung city TaiwanValuation Update With 7 Day Price Move • Nov 28Investor sentiment improves as stock rises 15%After last week's 15% share price gain to NT$30.90, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 11x in the Medical Equipment industry in Taiwan. Total returns to shareholders of 24% over the past three years.Reported Earnings • Nov 12Third quarter 2025 earnings: EPS and revenues miss analyst expectationsThird quarter 2025 results: EPS: NT$0.36 (up from NT$0.33 loss in 3Q 2024). Revenue: NT$250.1m (up 7.0% from 3Q 2024). Net income: NT$19.5m (up NT$37.7m from 3Q 2024). Profit margin: 7.8% (up from net loss in 3Q 2024). The move to profitability was primarily driven by lower expenses. Revenue missed analyst estimates by 24%. Earnings per share (EPS) also missed analyst estimates by 16%. Revenue is forecast to grow 22% p.a. on average during the next 2 years, compared to a 97% growth forecast for the Medical Equipment industry in Taiwan. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.New Risk • Nov 12New major risk - Revenue and earnings growthEarnings have declined by 16% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 16% per year over the past 5 years. Minor Risk Market cap is less than US$100m (NT$1.40b market cap, or US$45.0m).New Risk • Oct 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (6.5% average weekly change). Market cap is less than US$100m (NT$1.52b market cap, or US$50.2m).Valuation Update With 7 Day Price Move • Sep 08Investor sentiment improves as stock rises 15%After last week's 15% share price gain to NT$34.45, the stock trades at a trailing P/E ratio of 24.7x. Average trailing P/E is 23x in the Medical Equipment industry in Taiwan. Total returns to shareholders of 35% over the past three years.Reported Earnings • Aug 15Second quarter 2025 earnings released: EPS: NT$0.34 (vs NT$0.15 in 2Q 2024)Second quarter 2025 results: EPS: NT$0.34 (up from NT$0.15 in 2Q 2024). Revenue: NT$368.5m (up 22% from 2Q 2024). Net income: NT$18.3m (up 122% from 2Q 2024). Profit margin: 5.0% (up from 2.7% in 2Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 15% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Aug 08Investor sentiment improves as stock rises 17%After last week's 17% share price gain to NT$27.95, the stock trades at a trailing P/E ratio of 23.2x. Average trailing P/E is 21x in the Medical Equipment industry in Taiwan. Total returns to shareholders of 12% over the past three years.Declared Dividend • Jun 14Dividend increased to NT$0.40Dividend of NT$0.40 is 300% higher than last year. Ex-date: 9th July 2025 Payment date: 31st July 2025 Dividend yield will be 1.8%, which is lower than the industry average of 3.7%. Sustainability & Growth Dividend is well covered by both earnings (34% earnings payout ratio) and cash flows (14% cash payout ratio). The dividend has increased by an average of 8.8% per year over the past 9 years. However, payments have been volatile during that time. Earnings per share has remained steady over the last 5 years. Unless this trend deteriorates, it should provide adequate earnings cover for the dividend.Reported Earnings • May 18First quarter 2025 earnings released: EPS: NT$0.29 (vs NT$0.14 loss in 1Q 2024)First quarter 2025 results: EPS: NT$0.29 (up from NT$0.14 loss in 1Q 2024). Revenue: NT$281.3m (up 11% from 1Q 2024). Net income: NT$15.5m (up NT$23.2m from 1Q 2024). Profit margin: 5.5% (up from net loss in 1Q 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 34% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings.お知らせ • May 06CVC Technologies Inc. to Report Q1, 2025 Results on May 13, 2025CVC Technologies Inc. announced that they will report Q1, 2025 results on May 13, 2025お知らせ • Mar 14+ 2 more updatesCVC Technologies Inc. announced a financing transactionCVC Technologies Inc. announced private placement on March 13, 2025. The company will issue up to 6,000,000 shares. The par value of each share is TWD10. The transaction has obtained board of directors approval.お知らせ • Mar 06CVC Technologies Inc. to Report Fiscal Year 2024 Results on Mar 13, 2025CVC Technologies Inc. announced that they will report fiscal year 2024 results on Mar 13, 2025Reported Earnings • Nov 18Third quarter 2024 earnings released: NT$0.33 loss per share (vs NT$0.44 profit in 3Q 2023)Third quarter 2024 results: NT$0.33 loss per share (down from NT$0.44 profit in 3Q 2023). Revenue: NT$233.7m (down 20% from 3Q 2023). Net loss: NT$18.2m (down 178% from profit in 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 52% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings.Reported Earnings • Aug 17Second quarter 2024 earnings released: EPS: NT$0.15 (vs NT$0.53 in 2Q 2023)Second quarter 2024 results: EPS: NT$0.15 (down from NT$0.53 in 2Q 2023). Revenue: NT$302.0m (down 3.7% from 2Q 2023). Net income: NT$8.25m (down 70% from 2Q 2023). Profit margin: 2.7% (down from 8.7% in 2Q 2023). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 42% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings.お知らせ • Aug 06CVC Technologies Inc. to Report Q2, 2024 Results on Aug 13, 2024CVC Technologies Inc. announced that they will report Q2, 2024 results on Aug 13, 2024Upcoming Dividend • Jul 09Upcoming dividend of NT$0.10 per shareEligible shareholders must have bought the stock before 16 July 2024. Payment date: 07 August 2024. Payout ratio is a comfortable 7.8% but the company is paying out more than the cash it is generating. Trailing yield: 0.4%. Lower than top quartile of Taiwanese dividend payers (4.2%). Lower than average of industry peers (3.0%).Reported Earnings • May 19First quarter 2024 earnings released: NT$0.14 loss per share (vs NT$1.29 loss in 1Q 2023)First quarter 2024 results: NT$0.14 loss per share (improved from NT$1.29 loss in 1Q 2023). Revenue: NT$253.3m (up 164% from 1Q 2023). Net loss: NT$7.67m (loss narrowed 88% from 1Q 2023). Over the last 3 years on average, earnings per share has fallen by 48% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings.お知らせ • May 15CVC Technologies Inc. Appoints Chen, Chun-Jen as Member to the Remuneration CommitteeCVC Technologies Inc. announced the appointment of member to the Remuneration Committee by the Board of Directors. Name of the new position holder: Chen, Chun-Jen. Resume of the new position holder: Professor of Law, National Cheng Kung University. Original term is from June 15, 2023 to June 14, 2026. Effective date of the new member is May 14, 2024.お知らせ • May 08CVC Technologies Inc. to Report Q1, 2024 Results on May 14, 2024CVC Technologies Inc. announced that they will report Q1, 2024 results at 9:00 AM, Taipei Standard Time on May 14, 2024New Risk • Apr 14New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 25% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 24% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.3% net profit margin). Shareholders have been diluted in the past year (8.7% increase in shares outstanding). Market cap is less than US$100m (NT$1.34b market cap, or US$41.5m).Reported Earnings • Apr 03Full year 2023 earnings released: EPS: NT$0.27 (vs NT$1.24 in FY 2022)Full year 2023 results: EPS: NT$0.27 (down from NT$1.24 in FY 2022). Revenue: NT$1.13b (up 25% from FY 2022). Net income: NT$14.4m (down 75% from FY 2022). Profit margin: 1.3% (down from 6.2% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 54% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings.お知らせ • Mar 16CVC Technologies Inc., Annual General Meeting, Jun 19, 2024CVC Technologies Inc., Annual General Meeting, Jun 19, 2024. Location: 4F., No.190, Gongye 9th Rd. Dali Dist. Taichung City Taiwan Agenda: To report the business of 2023; to consider Audit Committee's review report of 2023; to report 2023 employees profit sharing bonus and directors compensation; to report the proposal for cash distribution of 2023 earnings; to report performance evaluation results of directors and managerial personnel relevant to reasonable compensation; and to accept 2023 Business Report, Financial Statements, and Earnings Distribution Table.お知らせ • Mar 15+ 1 more updateCVC Technologies Inc. Announces the Resignation of Su, Song-Hui as Independent Director as A Member of the Audit Committee and Remuneration CommitteeCVC Technologies Inc. announced the resignation of Su, Song-Hui as Independent Director as a member of the Audit Committee and Remuneration Committee, effective March 13, 2024.お知らせ • Mar 14CVC Technologies Inc. Announces the Resignation of Su, Song-Hui as Independent DirectorCVC Technologies Inc. announced the resignation of Su, Song-Hui as Independent director, effective March 13, 2024.お知らせ • Dec 01CVC Technologies Inc. Appoints Lin,Jing-Yi as ChairpersonCVC Technologies Inc. announced the change of the company's Chairperson and Vice chairperson. Name of the previous position holder: Vice chairperson: Lin,Jing-Yi. Name of the new position holder: Chairperson: Lin,Jing-Yi. Resume of the new position holder: Chairperson: Vice chairperson of the company. The chairperson resigned on November 21,2023, The board of directors elected Vice chairperson as Chairperson. Effective date of the new appointment: November 30, 2023.お知らせ • Nov 22+ 1 more updateCVC Technologies Inc. Announces Resignation of Yan,De-Xin as ChairpersonCVC Technologies Inc. announced resignation of Yan,De-Xin as Chairperson of the company. The company received the resignation letter on November 21, 2023, and the effective date is November 21, 2023.Reported Earnings • Nov 15Third quarter 2023 earnings released: EPS: NT$0.44 (vs NT$0.80 in 3Q 2022)Third quarter 2023 results: EPS: NT$0.44 (down from NT$0.80 in 3Q 2022). Revenue: NT$293.1m (up 50% from 3Q 2022). Net income: NT$23.3m (down 35% from 3Q 2022). Profit margin: 8.0% (down from 18% in 3Q 2022). Over the last 3 years on average, earnings per share has fallen by 45% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.New Risk • Oct 11New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Cash payout ratio: 126% Earnings have declined by 12% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (6.2% average weekly change). Shareholders have been diluted in the past year (27% increase in shares outstanding). Market cap is less than US$100m (NT$1.71b market cap, or US$53.2m).Upcoming Dividend • Aug 11Upcoming dividend of NT$0.93 per share at 3.2% yieldEligible shareholders must have bought the stock before 18 August 2023. Payment date: 14 September 2023. The company is not currently making a profit but it is cash flow positive. Trailing yield: 3.2%. Lower than top quartile of Taiwanese dividend payers (5.6%). Lower than average of industry peers (3.6%).お知らせ • Jul 25Cvc Technologies Inc. Announces Dividend Distribution, Payable on September 14, 2023CVC Technologies Inc. announced dividend distribution of 51,297,539. Payment date of cash dividend distribution on September 14, 2023. Ex-rights (Ex-dividend) record date on August 26, 2023.New Risk • Jul 18New major risk - Revenue and earnings growthEarnings have declined by 5.6% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 5.6% per year over the past 5 years. Minor Risks Paying a dividend despite being loss-making. Share price has been volatile over the past 3 months (6.5% average weekly change). Shareholders have been diluted in the past year (17% increase in shares outstanding). Market cap is less than US$100m (NT$1.71b market cap, or US$55.2m).Valuation Update With 7 Day Price Move • Jul 12Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to NT$35.65, the stock trades at a trailing P/E ratio of 32.1x. Average trailing P/E is 26x in the Medical Equipment industry in Taiwan. Total returns to shareholders of 14% over the past three years.お知らせ • Jun 17+ 2 more updatesCVC Technologies Inc. Approves Dividend for 2022CVC Technologies Inc. at its shareholder meeting held on June 15, 2023, approved the dividend of TWD 1 per share for 2022.Valuation Update With 7 Day Price Move • May 08Investor sentiment improves as stock rises 23%After last week's 23% share price gain to NT$42.80, the stock trades at a trailing P/E ratio of 38.5x. Average trailing P/E is 22x in the Medical Equipment industry in Taiwan. Total returns to shareholders of 38% over the past three years.Reported Earnings • Mar 30Full year 2022 earnings released: EPS: NT$1.24 (vs NT$1.71 in FY 2021)Full year 2022 results: EPS: NT$1.24 (down from NT$1.71 in FY 2021). Revenue: NT$902.8m (down 18% from FY 2021). Net income: NT$56.3m (down 26% from FY 2021). Profit margin: 6.2% (down from 7.0% in FY 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 3% per year whereas the company’s share price has increased by 1% per year.Valuation Update With 7 Day Price Move • Feb 06Investor sentiment improves as stock rises 16%After last week's 16% share price gain to NT$31.15, the stock trades at a trailing P/E ratio of 15.7x. Average trailing P/E is 20x in the Medical Equipment industry in Taiwan. Total loss to shareholders of 2.5% over the past three years.Reported Earnings • Nov 16Third quarter 2022 earnings released: EPS: NT$0.80 (vs NT$0.85 in 3Q 2021)Third quarter 2022 results: EPS: NT$0.80 (down from NT$0.85 in 3Q 2021). Revenue: NT$196.1m (down 28% from 3Q 2021). Net income: NT$35.7m (down 5.0% from 3Q 2021). Profit margin: 18% (up from 14% in 3Q 2021). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 2 independent directors (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Reported Earnings • Nov 13Third quarter 2022 earnings released: EPS: NT$0.80 (vs NT$0.85 in 3Q 2021)Third quarter 2022 results: EPS: NT$0.80 (down from NT$0.85 in 3Q 2021). Revenue: NT$196.1m (down 28% from 3Q 2021). Net income: NT$35.7m (down 5.0% from 3Q 2021). Profit margin: 18% (up from 14% in 3Q 2021). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.Reported Earnings • Aug 15Second quarter 2022 earnings released: EPS: NT$0.68 (vs NT$0.065 in 2Q 2021)Second quarter 2022 results: EPS: NT$0.68 (up from NT$0.065 in 2Q 2021). Revenue: NT$212.5m (up 2.4% from 2Q 2021). Net income: NT$29.5m (up NT$26.6m from 2Q 2021). Profit margin: 14% (up from 1.4% in 2Q 2021). The increase in margin was primarily driven by lower expenses. Over the last 3 years on average, earnings per share has remained flat whereas the company’s share price has fallen by 1% per year.お知らせ • Aug 09CVC Technologies Inc. Announces Dismissal of Chin-Chia Chang as General ManagerCVC Technologies Inc. announced change of the General Manager. Name of the previous position holder: Chin-Chia Chang. Resume of the previous position holder: General manager & CFO of parent company. Reason for the change: dismissal. Any other matters that need to be specified: From August 8, 2022, MIN,WEI-JIE, the sales director of subsidiary CVC Technologies Inc, also serves as the deputy general manager to execute the general manager's business.Upcoming Dividend • Aug 08Upcoming dividend of NT$1.20 per shareEligible shareholders must have bought the stock before 15 August 2022. Payment date: 06 September 2022. Payout ratio is a comfortable 73% but the company is paying out more than the cash it is generating. Trailing yield: 4.2%. Lower than top quartile of Taiwanese dividend payers (6.6%). Higher than average of industry peers (3.6%).お知らせ • Jul 30CVC Technologies Inc. Announces Adjust Cash Dividend RatioCVC Technologies Inc. held its shareholders meeting on July 29, 2022, approved Type and monetary amount of original dividend distribution: Dividend is TWD 1.2 per share, cash dividend totaling is TWD 53,450,432. Type and monetary amount of dividend distribution after the change: The adjusted dividend is TWD 1.19911738 per share, cash dividend totaling is TWD 53,450,432.お知らせ • Jul 21CVC Technologies Inc. Announces Cash Dividend, Payable on September 6, 2022CVC Technologies Inc. announced cash dividend of TWD 53,450,432. Ex-rights (Ex-dividend) date is August 15, 2022. Last date before book closure is August 16, 2022. Ex-rights (Ex-dividend) record date is August 21, 2022. Payment date of cash dividend distribution is September 6, 2022.Valuation Update With 7 Day Price Move • Jul 11Investor sentiment improved over the past weekAfter last week's 21% share price gain to NT$28.45, the stock trades at a trailing P/E ratio of 16.9x. Average trailing P/E is 19x in the Medical Equipment industry in Taiwan. Total returns to shareholders of 4.8% over the past three years.Reported Earnings • May 16First quarter 2022 earnings released: EPS: NT$0.01 (vs NT$0.083 in 1Q 2021)First quarter 2022 results: EPS: NT$0.01 (down from NT$0.083 in 1Q 2021). Revenue: NT$171.1m (down 18% from 1Q 2021). Net income: NT$401.0k (down 89% from 1Q 2021). Profit margin: 0.2% (down from 1.8% in 1Q 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 5% per year whereas the company’s share price has fallen by 1% per year.Valuation Update With 7 Day Price Move • Apr 28Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to NT$28.85, the stock trades at a trailing P/E ratio of 16.4x. Average trailing P/E is 24x in the Medical Equipment industry in Taiwan. Total returns to shareholders of 11% over the past three years.Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 2 independent directors (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Valuation Update With 7 Day Price Move • Apr 08Investor sentiment improved over the past weekAfter last week's 15% share price gain to NT$35.50, the stock trades at a trailing P/E ratio of 20.1x. Average trailing P/E is 23x in the Medical Equipment industry in Taiwan. Total returns to shareholders of 29% over the past three years.Reported Earnings • Mar 28Full year 2021 earnings released: EPS: NT$1.71 (vs NT$1.52 in FY 2020)Full year 2021 results: EPS: NT$1.71 (up from NT$1.52 in FY 2020). Revenue: NT$1.09b (up 6.5% from FY 2020). Net income: NT$76.2m (up 12% from FY 2020). Profit margin: 7.0% (up from 6.6% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has remained flat, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Feb 15Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to NT$31.25, the stock trades at a trailing P/E ratio of 19.5x. Average trailing P/E is 25x in the Medical Equipment industry in Taiwan. Total returns to shareholders of 19% over the past three years.Valuation Update With 7 Day Price Move • Dec 10Investor sentiment improved over the past weekAfter last week's 15% share price gain to NT$31.95, the stock trades at a trailing P/E ratio of 20.5x. Average trailing P/E is 26x in the Medical Equipment industry in Taiwan. Total returns to shareholders of 8.7% over the past three years.Reported Earnings • Nov 15Third quarter 2021 earnings released: EPS NT$0.84 (vs NT$0.45 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: NT$274.4m (up 4.2% from 3Q 2020). Net income: NT$37.6m (up 87% from 3Q 2020). Profit margin: 14% (up from 7.6% in 3Q 2020). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 5% per year whereas the company’s share price has fallen by 3% per year.Reported Earnings • Aug 18Second quarter 2021 earnings released: EPS NT$0.07 (vs NT$0.91 in 2Q 2020)The company reported a poor second quarter result with weaker earnings, revenues and profit margins. Second quarter 2021 results: Revenue: NT$207.4m (down 27% from 2Q 2020). Net income: NT$2.90m (down 93% from 2Q 2020). Profit margin: 1.4% (down from 14% in 2Q 2020). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 4% per year whereas the company’s share price has fallen by 9% per year.Upcoming Dividend • Aug 18Upcoming dividend of NT$1.20 per shareEligible shareholders must have bought the stock before 25 August 2021. Payment date: 17 September 2021. Trailing yield: 4.4%. Lower than top quartile of Taiwanese dividend payers (5.3%). Higher than average of industry peers (3.1%).Reported Earnings • May 17First quarter 2021 earnings released: EPS NT$0.08 (vs NT$0.39 loss in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: NT$209.6m (up 18% from 1Q 2020). Net income: NT$3.69m (up NT$21.5m from 1Q 2020). Profit margin: 1.8% (up from net loss in 1Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has fallen by 14% per year, which means it is performing significantly worse than earnings.分析記事 • Apr 13CVC Technologies (GTSM:4744) Could Be Struggling To Allocate CapitalIf you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...分析記事 • Mar 26Is CVC Technologies Inc. (GTSM:4744) A Risky Dividend Stock?Is CVC Technologies Inc. ( GTSM:4744 ) a good dividend stock? How can we tell? Dividend paying companies with growing...Reported Earnings • Mar 26Full year 2020 earnings released: EPS NT$1.52 (vs NT$2.05 in FY 2019)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: NT$1.03b (down 8.4% from FY 2019). Net income: NT$67.9m (down 27% from FY 2019). Profit margin: 6.6% (down from 8.3% in FY 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings.お知らせ • Mar 20CVC Technologies Inc. Announces Change of the General ManagerCVC Technologies Inc. announced the resignation of Kai-Hsun Chang as general manager and appointment of Chin-Chia Chang as general manager, effective March 18, 2021.お知らせ • Mar 19+ 1 more updateCvc Technologies Inc. Announces Replacement of the Financial OfficerCVC Technologies Inc. announced Chin-Chia Chang replaced Han-Nung Chen as accounting officer and financial officer. Effective date is March 18, 2021.分析記事 • Mar 08Estimating The Fair Value Of CVC Technologies Inc. (GTSM:4744)Does the March share price for CVC Technologies Inc. ( GTSM:4744 ) reflect what it's really worth? Today, we will...分析記事 • Feb 17Is CVC Technologies Inc.'s (GTSM:4744) Recent Performancer Underpinned By Weak Financials?CVC Technologies (GTSM:4744) has had a rough three months with its share price down 10%. To decide if this trend could...分析記事 • Jan 30Is CVC Technologies (GTSM:4744) A Risky Investment?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...分析記事 • Jan 12We Like These Underlying Trends At CVC Technologies (GTSM:4744)What are the early trends we should look for to identify a stock that could multiply in value over the long term? One...Is New 90 Day High Low • Jan 11New 90-day low: NT$28.50The company is down 12% from its price of NT$32.30 on 14 October 2020. The Taiwanese market is up 19% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Medical Equipment industry, which is down 4.0% over the same period.分析記事 • Dec 25Read This Before Buying CVC Technologies Inc. (GTSM:4744) For Its DividendDividend paying stocks like CVC Technologies Inc. ( GTSM:4744 ) tend to be popular with investors, and for good reason...Is New 90 Day High Low • Dec 17New 90-day low: NT$29.70The company is down 6.0% from its price of NT$31.60 on 18 September 2020. The Taiwanese market is up 10.0% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Medical Equipment industry, which is down 7.0% over the same period.分析記事 • Dec 07Estimating The Intrinsic Value Of CVC Technologies Inc. (GTSM:4744)In this article we are going to estimate the intrinsic value of CVC Technologies Inc. ( GTSM:4744 ) by taking the...Is New 90 Day High Low • Dec 02New 90-day low: NT$30.35The company is down 3.0% from its price of NT$31.30 on 03 September 2020. The Taiwanese market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Medical Equipment industry, which is down 1.0% over the same period.Reported Earnings • Nov 14Third quarter 2020 earnings released: EPS NT$0.45The company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2020 results: Revenue: NT$263.3m (down 1.8% from 3Q 2019). Net income: NT$20.1m (down 12% from 3Q 2019). Profit margin: 7.6% (down from 8.5% in 3Q 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.お知らせ • Nov 06CVC Technologies Inc. Announces Change of the General ManagerCVC Technologies Inc. announced change of the General Manager. Name and resume of the previous position holder: YEH, CHIH-MING /General Manager of Cvc Technologies Inc. Name and resume of the new position holder: CHANG, KAI-HSUN /Sales Vice General Manager of Cvc Technologies Inc. Date of occurrence of the change is November 5, 2020.株主還元4744TW Medical EquipmentTW 市場7D-11.4%2.0%-0.5%1Y11.4%-30.1%104.1%株主還元を見る業界別リターン: 4744過去 1 年間で-30.1 % の収益を上げたTW Medical Equipment業界を上回りました。リターン対市場: 4744は、過去 1 年間で104.1 % のリターンを上げたTW市場を下回りました。価格変動Is 4744's price volatile compared to industry and market?4744 volatility4744 Average Weekly Movement8.4%Medical Equipment Industry Average Movement4.4%Market Average Movement6.4%10% most volatile stocks in TW Market12.0%10% least volatile stocks in TW Market2.6%安定した株価: 4744 、 TW市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: 4744の 週次ボラティリティ ( 8% ) は過去 1 年間安定しています。会社概要設立従業員CEO（最高経営責任者ウェブサイト1979n/an/awww.cvctechnologies.com.twCVC Technologies Inc.は、様々なタイプの医薬品包装機を世界中で製造・販売しています。同社は、ボトルアンスクランブラーやエアリンサーなどの錠剤計数機、錠剤/カプセルカウンターと充填機、乾燥剤インサーター、綿/発泡インサーター、チャック、ロータリー、バイアル、インライン、振動プレスキャッパーなどのキャッパー、誘導キャップシーラー、シュリンクバンドルとトンネル、間欠カートナー、およびトラック＆トレースマシンを提供しています。また、トップ/ボトム/サイドラベラー、ラップアラウンドラベラー、フロント/バックラベラー、リーフレットトップサーター、シュリンクスリーブアプリケーター、ラベラー検査システムなどのラベリングマシン、ボトルアンスクランブラーやエアリンサー、液体充填機やキャッパー、キャッパーマシン、インダクションキャップシーラー、ラベリングマシン、カートナー/シュリンクマシンなどの液体・粉末充填機も提供している；カプセル充填機、ジェットマスター、カプセル印刷機、ペースト製造システム、ゼラチン溶解タンク、薬液調製システム、乾燥システム、ゼラチン再生システム、カプセル検査機などの補助装置、アルミ箔シール機、半自動錠剤・カプセルカウンター。さらに、包装ライン設計、工場受入試験、技術電話サポート、フィールドサービスおよび予防保守サービス、設置、立ち上げ、トレーニングサービスも提供している。同社は1979年に設立され、台湾の台中に本社を置いている。もっと見るCVC Technologies Inc. 基礎のまとめCVC Technologies の収益と売上を時価総額と比較するとどうか。4744 基礎統計学時価総額NT$1.42b収益（TTM）NT$113.31m売上高(TTM)NT$1.40b12.2xPER（株価収益率1.0xP/Sレシオ4744 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計4744 損益計算書（TTM）収益NT$1.40b売上原価NT$797.39m売上総利益NT$605.99mその他の費用NT$492.69m収益NT$113.31m直近の収益報告Mar 31, 2026次回決算日該当なし一株当たり利益（EPS）2.04グロス・マージン43.18%純利益率8.07%有利子負債／自己資本比率38.2%4744 の長期的なパフォーマンスは？過去の実績と比較を見る配当金4.0%現在の配当利回り48%配当性向View Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/26 11:44終値2026/06/26 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋CVC Technologies Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Hsiu Chi LinMasterlink Securities Investment Advisory
Valuation Update With 7 Day Price Move • Jun 15Investor sentiment deteriorates as stock falls 25%After last week's 25% share price decline to NT$27.40, the stock trades at a trailing P/E ratio of 13.1x. Average forward P/E is 11x in the Medical Equipment industry in Taiwan. Total loss to shareholders of 28% over the past three years.
Reported Earnings • May 15First quarter 2026 earnings released: NT$0.11 loss per share (vs NT$0.29 profit in 1Q 2025)First quarter 2026 results: NT$0.11 loss per share (down from NT$0.29 profit in 1Q 2025). Revenue: NT$240.0m (down 15% from 1Q 2025). Net loss: NT$6.16m (down 140% from profit in 1Q 2025). Over the last 3 years on average, earnings per share has increased by 85% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings.
New Risk • Apr 10New minor risk - Dividend sustainabilityThe dividend is not well covered by cash flows. The company is paying a dividend despite having no free cash flows. Dividend yield: 3.0% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Market cap is less than US$100m (NT$1.80b market cap, or US$56.6m).
Reported Earnings • Mar 14Full year 2025 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2025 results: EPS: NT$2.51 (up from NT$0.75 in FY 2024). Revenue: NT$1.44b (up 12% from FY 2024). Net income: NT$135.0m (up 227% from FY 2024). Profit margin: 9.3% (up from 3.2% in FY 2024). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 7.4%. Earnings per share (EPS) exceeded analyst estimates by 17%. Over the last 3 years on average, earnings per share has increased by 68% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.
お知らせ • Mar 13CVC Technologies Inc., Annual General Meeting, Jun 11, 2026CVC Technologies Inc., Annual General Meeting, Jun 11, 2026. Location: 2 floor no,2, kung yeh rd., dali district, taichung city Taiwan
Valuation Update With 7 Day Price Move • Nov 28Investor sentiment improves as stock rises 15%After last week's 15% share price gain to NT$30.90, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 11x in the Medical Equipment industry in Taiwan. Total returns to shareholders of 24% over the past three years.
Valuation Update With 7 Day Price Move • Jun 15Investor sentiment deteriorates as stock falls 25%After last week's 25% share price decline to NT$27.40, the stock trades at a trailing P/E ratio of 13.1x. Average forward P/E is 11x in the Medical Equipment industry in Taiwan. Total loss to shareholders of 28% over the past three years.
Reported Earnings • May 15First quarter 2026 earnings released: NT$0.11 loss per share (vs NT$0.29 profit in 1Q 2025)First quarter 2026 results: NT$0.11 loss per share (down from NT$0.29 profit in 1Q 2025). Revenue: NT$240.0m (down 15% from 1Q 2025). Net loss: NT$6.16m (down 140% from profit in 1Q 2025). Over the last 3 years on average, earnings per share has increased by 85% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings.
New Risk • Apr 10New minor risk - Dividend sustainabilityThe dividend is not well covered by cash flows. The company is paying a dividend despite having no free cash flows. Dividend yield: 3.0% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Market cap is less than US$100m (NT$1.80b market cap, or US$56.6m).
Reported Earnings • Mar 14Full year 2025 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2025 results: EPS: NT$2.51 (up from NT$0.75 in FY 2024). Revenue: NT$1.44b (up 12% from FY 2024). Net income: NT$135.0m (up 227% from FY 2024). Profit margin: 9.3% (up from 3.2% in FY 2024). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 7.4%. Earnings per share (EPS) exceeded analyst estimates by 17%. Over the last 3 years on average, earnings per share has increased by 68% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.
お知らせ • Mar 13CVC Technologies Inc., Annual General Meeting, Jun 11, 2026CVC Technologies Inc., Annual General Meeting, Jun 11, 2026. Location: 2 floor no,2, kung yeh rd., dali district, taichung city Taiwan
Valuation Update With 7 Day Price Move • Nov 28Investor sentiment improves as stock rises 15%After last week's 15% share price gain to NT$30.90, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 11x in the Medical Equipment industry in Taiwan. Total returns to shareholders of 24% over the past three years.
Reported Earnings • Nov 12Third quarter 2025 earnings: EPS and revenues miss analyst expectationsThird quarter 2025 results: EPS: NT$0.36 (up from NT$0.33 loss in 3Q 2024). Revenue: NT$250.1m (up 7.0% from 3Q 2024). Net income: NT$19.5m (up NT$37.7m from 3Q 2024). Profit margin: 7.8% (up from net loss in 3Q 2024). The move to profitability was primarily driven by lower expenses. Revenue missed analyst estimates by 24%. Earnings per share (EPS) also missed analyst estimates by 16%. Revenue is forecast to grow 22% p.a. on average during the next 2 years, compared to a 97% growth forecast for the Medical Equipment industry in Taiwan. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.
New Risk • Nov 12New major risk - Revenue and earnings growthEarnings have declined by 16% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 16% per year over the past 5 years. Minor Risk Market cap is less than US$100m (NT$1.40b market cap, or US$45.0m).
New Risk • Oct 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (6.5% average weekly change). Market cap is less than US$100m (NT$1.52b market cap, or US$50.2m).
Valuation Update With 7 Day Price Move • Sep 08Investor sentiment improves as stock rises 15%After last week's 15% share price gain to NT$34.45, the stock trades at a trailing P/E ratio of 24.7x. Average trailing P/E is 23x in the Medical Equipment industry in Taiwan. Total returns to shareholders of 35% over the past three years.
Reported Earnings • Aug 15Second quarter 2025 earnings released: EPS: NT$0.34 (vs NT$0.15 in 2Q 2024)Second quarter 2025 results: EPS: NT$0.34 (up from NT$0.15 in 2Q 2024). Revenue: NT$368.5m (up 22% from 2Q 2024). Net income: NT$18.3m (up 122% from 2Q 2024). Profit margin: 5.0% (up from 2.7% in 2Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 15% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Aug 08Investor sentiment improves as stock rises 17%After last week's 17% share price gain to NT$27.95, the stock trades at a trailing P/E ratio of 23.2x. Average trailing P/E is 21x in the Medical Equipment industry in Taiwan. Total returns to shareholders of 12% over the past three years.
Declared Dividend • Jun 14Dividend increased to NT$0.40Dividend of NT$0.40 is 300% higher than last year. Ex-date: 9th July 2025 Payment date: 31st July 2025 Dividend yield will be 1.8%, which is lower than the industry average of 3.7%. Sustainability & Growth Dividend is well covered by both earnings (34% earnings payout ratio) and cash flows (14% cash payout ratio). The dividend has increased by an average of 8.8% per year over the past 9 years. However, payments have been volatile during that time. Earnings per share has remained steady over the last 5 years. Unless this trend deteriorates, it should provide adequate earnings cover for the dividend.
Reported Earnings • May 18First quarter 2025 earnings released: EPS: NT$0.29 (vs NT$0.14 loss in 1Q 2024)First quarter 2025 results: EPS: NT$0.29 (up from NT$0.14 loss in 1Q 2024). Revenue: NT$281.3m (up 11% from 1Q 2024). Net income: NT$15.5m (up NT$23.2m from 1Q 2024). Profit margin: 5.5% (up from net loss in 1Q 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 34% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings.
お知らせ • May 06CVC Technologies Inc. to Report Q1, 2025 Results on May 13, 2025CVC Technologies Inc. announced that they will report Q1, 2025 results on May 13, 2025
お知らせ • Mar 14+ 2 more updatesCVC Technologies Inc. announced a financing transactionCVC Technologies Inc. announced private placement on March 13, 2025. The company will issue up to 6,000,000 shares. The par value of each share is TWD10. The transaction has obtained board of directors approval.
お知らせ • Mar 06CVC Technologies Inc. to Report Fiscal Year 2024 Results on Mar 13, 2025CVC Technologies Inc. announced that they will report fiscal year 2024 results on Mar 13, 2025
Reported Earnings • Nov 18Third quarter 2024 earnings released: NT$0.33 loss per share (vs NT$0.44 profit in 3Q 2023)Third quarter 2024 results: NT$0.33 loss per share (down from NT$0.44 profit in 3Q 2023). Revenue: NT$233.7m (down 20% from 3Q 2023). Net loss: NT$18.2m (down 178% from profit in 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 52% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings.
Reported Earnings • Aug 17Second quarter 2024 earnings released: EPS: NT$0.15 (vs NT$0.53 in 2Q 2023)Second quarter 2024 results: EPS: NT$0.15 (down from NT$0.53 in 2Q 2023). Revenue: NT$302.0m (down 3.7% from 2Q 2023). Net income: NT$8.25m (down 70% from 2Q 2023). Profit margin: 2.7% (down from 8.7% in 2Q 2023). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 42% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings.
お知らせ • Aug 06CVC Technologies Inc. to Report Q2, 2024 Results on Aug 13, 2024CVC Technologies Inc. announced that they will report Q2, 2024 results on Aug 13, 2024
Upcoming Dividend • Jul 09Upcoming dividend of NT$0.10 per shareEligible shareholders must have bought the stock before 16 July 2024. Payment date: 07 August 2024. Payout ratio is a comfortable 7.8% but the company is paying out more than the cash it is generating. Trailing yield: 0.4%. Lower than top quartile of Taiwanese dividend payers (4.2%). Lower than average of industry peers (3.0%).
Reported Earnings • May 19First quarter 2024 earnings released: NT$0.14 loss per share (vs NT$1.29 loss in 1Q 2023)First quarter 2024 results: NT$0.14 loss per share (improved from NT$1.29 loss in 1Q 2023). Revenue: NT$253.3m (up 164% from 1Q 2023). Net loss: NT$7.67m (loss narrowed 88% from 1Q 2023). Over the last 3 years on average, earnings per share has fallen by 48% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings.
お知らせ • May 15CVC Technologies Inc. Appoints Chen, Chun-Jen as Member to the Remuneration CommitteeCVC Technologies Inc. announced the appointment of member to the Remuneration Committee by the Board of Directors. Name of the new position holder: Chen, Chun-Jen. Resume of the new position holder: Professor of Law, National Cheng Kung University. Original term is from June 15, 2023 to June 14, 2026. Effective date of the new member is May 14, 2024.
お知らせ • May 08CVC Technologies Inc. to Report Q1, 2024 Results on May 14, 2024CVC Technologies Inc. announced that they will report Q1, 2024 results at 9:00 AM, Taipei Standard Time on May 14, 2024
New Risk • Apr 14New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 25% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 24% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.3% net profit margin). Shareholders have been diluted in the past year (8.7% increase in shares outstanding). Market cap is less than US$100m (NT$1.34b market cap, or US$41.5m).
Reported Earnings • Apr 03Full year 2023 earnings released: EPS: NT$0.27 (vs NT$1.24 in FY 2022)Full year 2023 results: EPS: NT$0.27 (down from NT$1.24 in FY 2022). Revenue: NT$1.13b (up 25% from FY 2022). Net income: NT$14.4m (down 75% from FY 2022). Profit margin: 1.3% (down from 6.2% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 54% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings.
お知らせ • Mar 16CVC Technologies Inc., Annual General Meeting, Jun 19, 2024CVC Technologies Inc., Annual General Meeting, Jun 19, 2024. Location: 4F., No.190, Gongye 9th Rd. Dali Dist. Taichung City Taiwan Agenda: To report the business of 2023; to consider Audit Committee's review report of 2023; to report 2023 employees profit sharing bonus and directors compensation; to report the proposal for cash distribution of 2023 earnings; to report performance evaluation results of directors and managerial personnel relevant to reasonable compensation; and to accept 2023 Business Report, Financial Statements, and Earnings Distribution Table.
お知らせ • Mar 15+ 1 more updateCVC Technologies Inc. Announces the Resignation of Su, Song-Hui as Independent Director as A Member of the Audit Committee and Remuneration CommitteeCVC Technologies Inc. announced the resignation of Su, Song-Hui as Independent Director as a member of the Audit Committee and Remuneration Committee, effective March 13, 2024.
お知らせ • Mar 14CVC Technologies Inc. Announces the Resignation of Su, Song-Hui as Independent DirectorCVC Technologies Inc. announced the resignation of Su, Song-Hui as Independent director, effective March 13, 2024.
お知らせ • Dec 01CVC Technologies Inc. Appoints Lin,Jing-Yi as ChairpersonCVC Technologies Inc. announced the change of the company's Chairperson and Vice chairperson. Name of the previous position holder: Vice chairperson: Lin,Jing-Yi. Name of the new position holder: Chairperson: Lin,Jing-Yi. Resume of the new position holder: Chairperson: Vice chairperson of the company. The chairperson resigned on November 21,2023, The board of directors elected Vice chairperson as Chairperson. Effective date of the new appointment: November 30, 2023.
お知らせ • Nov 22+ 1 more updateCVC Technologies Inc. Announces Resignation of Yan,De-Xin as ChairpersonCVC Technologies Inc. announced resignation of Yan,De-Xin as Chairperson of the company. The company received the resignation letter on November 21, 2023, and the effective date is November 21, 2023.
Reported Earnings • Nov 15Third quarter 2023 earnings released: EPS: NT$0.44 (vs NT$0.80 in 3Q 2022)Third quarter 2023 results: EPS: NT$0.44 (down from NT$0.80 in 3Q 2022). Revenue: NT$293.1m (up 50% from 3Q 2022). Net income: NT$23.3m (down 35% from 3Q 2022). Profit margin: 8.0% (down from 18% in 3Q 2022). Over the last 3 years on average, earnings per share has fallen by 45% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.
New Risk • Oct 11New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Cash payout ratio: 126% Earnings have declined by 12% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (6.2% average weekly change). Shareholders have been diluted in the past year (27% increase in shares outstanding). Market cap is less than US$100m (NT$1.71b market cap, or US$53.2m).
Upcoming Dividend • Aug 11Upcoming dividend of NT$0.93 per share at 3.2% yieldEligible shareholders must have bought the stock before 18 August 2023. Payment date: 14 September 2023. The company is not currently making a profit but it is cash flow positive. Trailing yield: 3.2%. Lower than top quartile of Taiwanese dividend payers (5.6%). Lower than average of industry peers (3.6%).
お知らせ • Jul 25Cvc Technologies Inc. Announces Dividend Distribution, Payable on September 14, 2023CVC Technologies Inc. announced dividend distribution of 51,297,539. Payment date of cash dividend distribution on September 14, 2023. Ex-rights (Ex-dividend) record date on August 26, 2023.
New Risk • Jul 18New major risk - Revenue and earnings growthEarnings have declined by 5.6% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 5.6% per year over the past 5 years. Minor Risks Paying a dividend despite being loss-making. Share price has been volatile over the past 3 months (6.5% average weekly change). Shareholders have been diluted in the past year (17% increase in shares outstanding). Market cap is less than US$100m (NT$1.71b market cap, or US$55.2m).
Valuation Update With 7 Day Price Move • Jul 12Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to NT$35.65, the stock trades at a trailing P/E ratio of 32.1x. Average trailing P/E is 26x in the Medical Equipment industry in Taiwan. Total returns to shareholders of 14% over the past three years.
お知らせ • Jun 17+ 2 more updatesCVC Technologies Inc. Approves Dividend for 2022CVC Technologies Inc. at its shareholder meeting held on June 15, 2023, approved the dividend of TWD 1 per share for 2022.
Valuation Update With 7 Day Price Move • May 08Investor sentiment improves as stock rises 23%After last week's 23% share price gain to NT$42.80, the stock trades at a trailing P/E ratio of 38.5x. Average trailing P/E is 22x in the Medical Equipment industry in Taiwan. Total returns to shareholders of 38% over the past three years.
Reported Earnings • Mar 30Full year 2022 earnings released: EPS: NT$1.24 (vs NT$1.71 in FY 2021)Full year 2022 results: EPS: NT$1.24 (down from NT$1.71 in FY 2021). Revenue: NT$902.8m (down 18% from FY 2021). Net income: NT$56.3m (down 26% from FY 2021). Profit margin: 6.2% (down from 7.0% in FY 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 3% per year whereas the company’s share price has increased by 1% per year.
Valuation Update With 7 Day Price Move • Feb 06Investor sentiment improves as stock rises 16%After last week's 16% share price gain to NT$31.15, the stock trades at a trailing P/E ratio of 15.7x. Average trailing P/E is 20x in the Medical Equipment industry in Taiwan. Total loss to shareholders of 2.5% over the past three years.
Reported Earnings • Nov 16Third quarter 2022 earnings released: EPS: NT$0.80 (vs NT$0.85 in 3Q 2021)Third quarter 2022 results: EPS: NT$0.80 (down from NT$0.85 in 3Q 2021). Revenue: NT$196.1m (down 28% from 3Q 2021). Net income: NT$35.7m (down 5.0% from 3Q 2021). Profit margin: 18% (up from 14% in 3Q 2021). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.
Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 2 independent directors (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Reported Earnings • Nov 13Third quarter 2022 earnings released: EPS: NT$0.80 (vs NT$0.85 in 3Q 2021)Third quarter 2022 results: EPS: NT$0.80 (down from NT$0.85 in 3Q 2021). Revenue: NT$196.1m (down 28% from 3Q 2021). Net income: NT$35.7m (down 5.0% from 3Q 2021). Profit margin: 18% (up from 14% in 3Q 2021). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.
Reported Earnings • Aug 15Second quarter 2022 earnings released: EPS: NT$0.68 (vs NT$0.065 in 2Q 2021)Second quarter 2022 results: EPS: NT$0.68 (up from NT$0.065 in 2Q 2021). Revenue: NT$212.5m (up 2.4% from 2Q 2021). Net income: NT$29.5m (up NT$26.6m from 2Q 2021). Profit margin: 14% (up from 1.4% in 2Q 2021). The increase in margin was primarily driven by lower expenses. Over the last 3 years on average, earnings per share has remained flat whereas the company’s share price has fallen by 1% per year.
お知らせ • Aug 09CVC Technologies Inc. Announces Dismissal of Chin-Chia Chang as General ManagerCVC Technologies Inc. announced change of the General Manager. Name of the previous position holder: Chin-Chia Chang. Resume of the previous position holder: General manager & CFO of parent company. Reason for the change: dismissal. Any other matters that need to be specified: From August 8, 2022, MIN,WEI-JIE, the sales director of subsidiary CVC Technologies Inc, also serves as the deputy general manager to execute the general manager's business.
Upcoming Dividend • Aug 08Upcoming dividend of NT$1.20 per shareEligible shareholders must have bought the stock before 15 August 2022. Payment date: 06 September 2022. Payout ratio is a comfortable 73% but the company is paying out more than the cash it is generating. Trailing yield: 4.2%. Lower than top quartile of Taiwanese dividend payers (6.6%). Higher than average of industry peers (3.6%).
お知らせ • Jul 30CVC Technologies Inc. Announces Adjust Cash Dividend RatioCVC Technologies Inc. held its shareholders meeting on July 29, 2022, approved Type and monetary amount of original dividend distribution: Dividend is TWD 1.2 per share, cash dividend totaling is TWD 53,450,432. Type and monetary amount of dividend distribution after the change: The adjusted dividend is TWD 1.19911738 per share, cash dividend totaling is TWD 53,450,432.
お知らせ • Jul 21CVC Technologies Inc. Announces Cash Dividend, Payable on September 6, 2022CVC Technologies Inc. announced cash dividend of TWD 53,450,432. Ex-rights (Ex-dividend) date is August 15, 2022. Last date before book closure is August 16, 2022. Ex-rights (Ex-dividend) record date is August 21, 2022. Payment date of cash dividend distribution is September 6, 2022.
Valuation Update With 7 Day Price Move • Jul 11Investor sentiment improved over the past weekAfter last week's 21% share price gain to NT$28.45, the stock trades at a trailing P/E ratio of 16.9x. Average trailing P/E is 19x in the Medical Equipment industry in Taiwan. Total returns to shareholders of 4.8% over the past three years.
Reported Earnings • May 16First quarter 2022 earnings released: EPS: NT$0.01 (vs NT$0.083 in 1Q 2021)First quarter 2022 results: EPS: NT$0.01 (down from NT$0.083 in 1Q 2021). Revenue: NT$171.1m (down 18% from 1Q 2021). Net income: NT$401.0k (down 89% from 1Q 2021). Profit margin: 0.2% (down from 1.8% in 1Q 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 5% per year whereas the company’s share price has fallen by 1% per year.
Valuation Update With 7 Day Price Move • Apr 28Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to NT$28.85, the stock trades at a trailing P/E ratio of 16.4x. Average trailing P/E is 24x in the Medical Equipment industry in Taiwan. Total returns to shareholders of 11% over the past three years.
Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 2 independent directors (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Valuation Update With 7 Day Price Move • Apr 08Investor sentiment improved over the past weekAfter last week's 15% share price gain to NT$35.50, the stock trades at a trailing P/E ratio of 20.1x. Average trailing P/E is 23x in the Medical Equipment industry in Taiwan. Total returns to shareholders of 29% over the past three years.
Reported Earnings • Mar 28Full year 2021 earnings released: EPS: NT$1.71 (vs NT$1.52 in FY 2020)Full year 2021 results: EPS: NT$1.71 (up from NT$1.52 in FY 2020). Revenue: NT$1.09b (up 6.5% from FY 2020). Net income: NT$76.2m (up 12% from FY 2020). Profit margin: 7.0% (up from 6.6% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has remained flat, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Feb 15Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to NT$31.25, the stock trades at a trailing P/E ratio of 19.5x. Average trailing P/E is 25x in the Medical Equipment industry in Taiwan. Total returns to shareholders of 19% over the past three years.
Valuation Update With 7 Day Price Move • Dec 10Investor sentiment improved over the past weekAfter last week's 15% share price gain to NT$31.95, the stock trades at a trailing P/E ratio of 20.5x. Average trailing P/E is 26x in the Medical Equipment industry in Taiwan. Total returns to shareholders of 8.7% over the past three years.
Reported Earnings • Nov 15Third quarter 2021 earnings released: EPS NT$0.84 (vs NT$0.45 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: NT$274.4m (up 4.2% from 3Q 2020). Net income: NT$37.6m (up 87% from 3Q 2020). Profit margin: 14% (up from 7.6% in 3Q 2020). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 5% per year whereas the company’s share price has fallen by 3% per year.
Reported Earnings • Aug 18Second quarter 2021 earnings released: EPS NT$0.07 (vs NT$0.91 in 2Q 2020)The company reported a poor second quarter result with weaker earnings, revenues and profit margins. Second quarter 2021 results: Revenue: NT$207.4m (down 27% from 2Q 2020). Net income: NT$2.90m (down 93% from 2Q 2020). Profit margin: 1.4% (down from 14% in 2Q 2020). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 4% per year whereas the company’s share price has fallen by 9% per year.
Upcoming Dividend • Aug 18Upcoming dividend of NT$1.20 per shareEligible shareholders must have bought the stock before 25 August 2021. Payment date: 17 September 2021. Trailing yield: 4.4%. Lower than top quartile of Taiwanese dividend payers (5.3%). Higher than average of industry peers (3.1%).
Reported Earnings • May 17First quarter 2021 earnings released: EPS NT$0.08 (vs NT$0.39 loss in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: NT$209.6m (up 18% from 1Q 2020). Net income: NT$3.69m (up NT$21.5m from 1Q 2020). Profit margin: 1.8% (up from net loss in 1Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has fallen by 14% per year, which means it is performing significantly worse than earnings.
分析記事 • Apr 13CVC Technologies (GTSM:4744) Could Be Struggling To Allocate CapitalIf you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
分析記事 • Mar 26Is CVC Technologies Inc. (GTSM:4744) A Risky Dividend Stock?Is CVC Technologies Inc. ( GTSM:4744 ) a good dividend stock? How can we tell? Dividend paying companies with growing...
Reported Earnings • Mar 26Full year 2020 earnings released: EPS NT$1.52 (vs NT$2.05 in FY 2019)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: NT$1.03b (down 8.4% from FY 2019). Net income: NT$67.9m (down 27% from FY 2019). Profit margin: 6.6% (down from 8.3% in FY 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings.
お知らせ • Mar 20CVC Technologies Inc. Announces Change of the General ManagerCVC Technologies Inc. announced the resignation of Kai-Hsun Chang as general manager and appointment of Chin-Chia Chang as general manager, effective March 18, 2021.
お知らせ • Mar 19+ 1 more updateCvc Technologies Inc. Announces Replacement of the Financial OfficerCVC Technologies Inc. announced Chin-Chia Chang replaced Han-Nung Chen as accounting officer and financial officer. Effective date is March 18, 2021.
分析記事 • Mar 08Estimating The Fair Value Of CVC Technologies Inc. (GTSM:4744)Does the March share price for CVC Technologies Inc. ( GTSM:4744 ) reflect what it's really worth? Today, we will...
分析記事 • Feb 17Is CVC Technologies Inc.'s (GTSM:4744) Recent Performancer Underpinned By Weak Financials?CVC Technologies (GTSM:4744) has had a rough three months with its share price down 10%. To decide if this trend could...
分析記事 • Jan 30Is CVC Technologies (GTSM:4744) A Risky Investment?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
分析記事 • Jan 12We Like These Underlying Trends At CVC Technologies (GTSM:4744)What are the early trends we should look for to identify a stock that could multiply in value over the long term? One...
Is New 90 Day High Low • Jan 11New 90-day low: NT$28.50The company is down 12% from its price of NT$32.30 on 14 October 2020. The Taiwanese market is up 19% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Medical Equipment industry, which is down 4.0% over the same period.
分析記事 • Dec 25Read This Before Buying CVC Technologies Inc. (GTSM:4744) For Its DividendDividend paying stocks like CVC Technologies Inc. ( GTSM:4744 ) tend to be popular with investors, and for good reason...
Is New 90 Day High Low • Dec 17New 90-day low: NT$29.70The company is down 6.0% from its price of NT$31.60 on 18 September 2020. The Taiwanese market is up 10.0% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Medical Equipment industry, which is down 7.0% over the same period.
分析記事 • Dec 07Estimating The Intrinsic Value Of CVC Technologies Inc. (GTSM:4744)In this article we are going to estimate the intrinsic value of CVC Technologies Inc. ( GTSM:4744 ) by taking the...
Is New 90 Day High Low • Dec 02New 90-day low: NT$30.35The company is down 3.0% from its price of NT$31.30 on 03 September 2020. The Taiwanese market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Medical Equipment industry, which is down 1.0% over the same period.
Reported Earnings • Nov 14Third quarter 2020 earnings released: EPS NT$0.45The company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2020 results: Revenue: NT$263.3m (down 1.8% from 3Q 2019). Net income: NT$20.1m (down 12% from 3Q 2019). Profit margin: 7.6% (down from 8.5% in 3Q 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.
お知らせ • Nov 06CVC Technologies Inc. Announces Change of the General ManagerCVC Technologies Inc. announced change of the General Manager. Name and resume of the previous position holder: YEH, CHIH-MING /General Manager of Cvc Technologies Inc. Name and resume of the new position holder: CHANG, KAI-HSUN /Sales Vice General Manager of Cvc Technologies Inc. Date of occurrence of the change is November 5, 2020.
